title: [Autologous blood pre-donation and perioperative use of erythropoietin].
abstract: The general concept of blood saving covers a number of technical and pharmacological actions which all aim to maintain the erythrocyte mass of the patient, and of which blood transfusion is only one. Severe anemia (Hb <60-80 g/l) increases postoperative mortality and morbidity. However, its correction by blood transfusion tends to worsen the prognosis. It is therefore imperative to conserve the patient's blood by any means possible. Detecting anemia is of primary importance. Whenever possible, its cause should be identified and treated. Depending on the detected anemia, as well as the blood loss expected during surgery, the patient should receive EPO (anemia with foreseeable moderate blood loss), or autologous pre-donation associated with EPO (anemia with foreseeable large blood loss).
authors.affiliation: Département d'anesthésiologie et de réanimation CHCVs, 1950 Sion. Burkhard.Michaeli@web.de
authors.forename: Burkhard
authors.initials: B
authors.lastname: Michaeli
authors.forename: Patrick
authors.initials: P
authors.lastname: Ravussin
authors.forename: Pierre-Guy
authors.initials: PG
authors.lastname: Chassot
mesh_terms: D000740:Anemia / Q000097:blood / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy; D016063:Blood Loss, Surgical; D001804:Blood Transfusion, Autologous; D004921:Erythropoietin / Q000008:administration & dosage / Q000627:therapeutic use*; D006400:Hematocrit; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D019990:Perioperative Care
chemical_list: D006454:Hemoglobins; D004921:Erythropoietin